Vinge Logotype
Svenska English 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge represents Apax Partners LLP in connection with the acquisition of stakes in Unilabs
Mandate

Vinge represents Apax Partners LLP in connection with the acquisition of stakes in Unilabs

December 16, 2016 M&A

Vinge, together with Simpson Thacher & Bartlett LLP, represents Apax Partners LLP in connection with the divestment by private equity funds Nordic Capital Fund VI and Apax France VII of their respective stakes in Unilabs to Apax IX, advised by Apax Partners LLP.

Unilabs is with over 5,300 employees and 112 laboratories one of Europe’s leading medical diagnostics businesses. Unilabs generated annual revenues of €673 million in 2015.

The transaction is subject to regulatory approvals and the financial terms of the transaction are not being disclosed.

The Vinge team includes partner Jonas Johansson together with, among others, Alex Miler and Rasmus Perdahl.

Related

Vinge advises Isofol Medical AB (publ) in connection with its rights issue of units

Through the rights issue of units, consisting of shares and warrants, and the exercised over-allotment issue, Isofol will receive approximately SEK 84 million and may receive an additional maximum of approximately SEK 110 million upon exercise of all warrants at the highest subscription price.
August 01, 2025

Vinge advises Oncorena in connection with share issue

 Vinge advises Oncorena Holding AB in connection with a share issue of approximately SEK 133 million.
July 30, 2025

Vinge advises Karl Hedin and minority owners on the sale of AB Karl Hedin Sågverk to Vida

 Vinge has advised Karl Hedin and minority shareholders in connection with the sale of AB Karl Hedin Sågverk to Vida Aktiebolag (“Vida”).
July 24, 2025